Wanfeng Guo

444 total citations
18 papers, 297 citations indexed

About

Wanfeng Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Wanfeng Guo has authored 18 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Wanfeng Guo's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Wanfeng Guo is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Wanfeng Guo collaborates with scholars based in China, United States and Hong Kong. Wanfeng Guo's co-authors include Chuanhao Tang, Haifeng Qin, Hongjun Gao, Samuel F. Miller, Michael Lynch, Jianjie Li, Xiaoqing Liu, Yi Liu, Haixu Hu and Sibel Küçükyıldırım and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Clinica Chimica Acta.

In The Last Decade

Wanfeng Guo

18 papers receiving 293 citations

Peers

Countries citing papers authored by Wanfeng Guo

Since Specialization

Citations

This map shows the geographic impact of Wanfeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanfeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanfeng Guo more than expected).

Fields of papers citing papers by Wanfeng Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanfeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanfeng Guo. The network helps show where Wanfeng Guo may publish in the future.

Co-authorship network of co-authors of Wanfeng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wanfeng Guo. A scholar is included among the top collaborators of Wanfeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanfeng Guo. Wanfeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Escherichia colicultures maintain stable subpopulation structure during long-term evolution 2018 ·Proceedings of the National Academy of Sciences ·Megan G. Behringer, (unknown), Samuel F. Miller, Thomas G. Doak, Jonathan A. Karty, Wanfeng Guo, Michael Lynch	31
2	Evolutionary determinants of genome-wide nucleotide composition 2017 ·Nature Ecology & Evolution ·Hongan Long, Way Sung, Sibel Küçükyıldırım, Emily Williams, Samuel F. Miller, Wanfeng Guo, (unknown), (unknown), (unknown), (unknown), Cécile Berne, David T. Kysela, William R. Shoemaker, Mario E. Muscarella, Haiwei Luo, Jay T. Lennon, Yves V. Brun, Michael Lynch	106
3	Fundamental effects of PD-1 antibody on the body: a brief report 2016 ·OncoTargets and Therapy ·Wei Wang, Bing Liu, Guangxian Liu, Wanfeng Guo	3
4	Evolution and prognosis of breast osteosarcoma: A case report 2015 ·Oncology Letters ·Wanfeng Guo, (unknown), Guangju Teng, Jin Liu, Jianbin Su	4
5	[Comparison of Efficacy and Safety of Different Therapeutic Regimens as  Second-line Treatment for Small Cell Lung Cancer]. 2015 ·SHILAP Revista de lepidopterología ·Zhihua Li, Xiaoqing Liu, Jianjie Li, Hongjun Gao, Chuanhao Tang, Xiaoyan Li, Wanfeng Guo, Haifeng Qin, Weixia Wang, Lili Qu, Jian Chen	2
6	Herpes B virus gD interaction with its human receptor - an in silico analysis approach 2014 ·Theoretical Biology and Medical Modelling ·(unknown), (unknown), Yan Li, Feng Liang, Huahu Ye, (unknown), Wanfeng Guo, Junjie Yue	5
7	Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients 2013 ·Clinica Chimica Acta ·Chuanhao Tang, Yi Liu, Haifeng Qin, Xiaoyan Li, Wanfeng Guo, Jianjie Li, Weixia Wang, Lili Qu, Haixu Hu, Chunhong Xu, Zheng Li, Yaohua Huang, Bing Liu, Hongjun Gao, Jussi M. Halleen, Xiaoqing Liu	29
8	[Clinic characteristics and prognosis in 102 non-small cell lung cancer patients less than 40 years old]. 2013 ·SHILAP Revista de lepidopterología ·Lili Qu, Haifeng Qin, Xiaoqing Liu, Hongjun Gao, Jianjie Li, Weixia Wang, Chuanhao Tang, Wanfeng Guo, Xiaoyan Li	2
9	[How to make the choice in the retreatment of EGFR-TKI for advanced NSCLC patients who benefited from prior gefitinib therapy: the original drug or switching to a second EGFR-TKI?]. 2013 ·SHILAP Revista de lepidopterología ·Chuanhao Tang, Xiaoyan Li, Wanfeng Guo, Jianjie Li, Haifeng Qin, Weixia Wang, Lili Qu, Juan An, Hongjun Gao, Xiaoqing Liu	4
10	[Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides]. 2013 ·SHILAP Revista de lepidopterología ·Juan An, Chuanhao Tang, Na Wang, (unknown), Wanfeng Guo, Xiaoyan Li, Zihe Wang, (unknown), Xiaoqing Liu	5
11	Randomized comparison of lobaplatin plus etoposide and cisplatin plus etoposide chemotherapy in patients with extensive-stage small cell lung cancer 2013 ·The Chinese-German Journal of Clinical Oncology ·Wanfeng Guo, Guoqing Liao, Hongjun Gao, Hongmei Wang, Chuanhao Tang, Haifeng Qin, Jianjie Li, Xiaoyan Li, Xiaoqing Liu	5
12	[Clinical investigation of efficacy of third-line and beyond pemetrexed treatment in advanced non-squamous non-small cell lung cancer]. 2012 ·SHILAP Revista de lepidopterología ·Fei Yu, Xiaoqing Liu, Xiaoyan Li, Jianjie Li, Wanfeng Guo, Haifeng Qin, Hongjun Gao	1
13	[Clinical observation of EGFR-TKI as a first-line therapy on advanced non-small cell lung cancer]. 2012 ·SHILAP Revista de lepidopterología ·Jianjie Li, Lili Qu, Xing Wei, Hongjun Gao, Weixia Wang, Haifeng Qin, Chuanhao Tang, Wanfeng Guo, Hong Wang, Xiaoqing Liu	13
14	A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients 2011 ·Journal of Experimental & Clinical Cancer Research ·Yi Liu, Bing Liu, Xiaoyan Li, Jianjie Li, Haifeng Qin, Chuanhao Tang, Wanfeng Guo, Haixu Hu, Sha Li, (unknown), Hongjun Gao, Xiaoqing Liu	58
15	Interleukin-4 -590T/C Polymorphism Influences the Susceptibility to Nonsmall Cell Lung Cancer 2011 ·DNA and Cell Biology ·Xiaoyan Li, Weiwei Shi, (unknown), (unknown), Bo Yang, Jianxiong Li, Wanfeng Guo, Chuanhao Tang, Hong Wang, Hongjun Gao, Haifeng Qin, Yi Liu, Xiaoqing Liu	16
16	Expression of Carbonic Anhydrase IX in NSCLC and its Relationship with VEGF and Ki67 Expression 2010 ·SHILAP Revista de lepidopterología ·(unknown), Xiaoqing Liu, Wanfeng Guo, (unknown)	4
17	[Expression of carbonic anhydrase IX in NSCLC and its relationship with VEGF and Ki67 expression]. 2010 ·Europe PMC (PubMed Central) ·(unknown), Xiaoqing Liu, Wanfeng Guo, Xiaobing Li	6
18	[Erlotinib in the treatment of advanced non-small-cell lung cancer (NSCLC)]. 2010 ·PubMed ·Chuanhao Tang, Xiaoqing Liu, Hongjun Gao, (unknown), Wanfeng Guo, Xiaoyan Li, Weixia Wang, Bing Liu, Lili Qu, Weiwei Wang	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact